AKYLA
Equity Research
Retail – Grocery Stores (SIC 5411)
Initiation of Coverage — LONG
Last Updated: June 28, 2026
Sprouts Farmers Market, Inc. (SFM)
A premium-grocer compounder hiding inside a soft-comp window — long with a path to a ~2x equity re-rate by mid-2028.
Thesis
- The market is pricing SFM as a cyclically-stalled grocer (1.7% comp decline in Q1 FY2026, EPS down 6% y/y) when the durable engine — ~10% annual unit growth, 26%+ Sprouts-brand penetration, organic at 34% of sales, and self-distribution margin capture — is fully intact. The soft comp is a lapping artifact (a FY2025 competitor strike, a favorable produce season, and a peer cyber incident), not a demand break, and management is guiding to sequential improvement back into its 3–4% comp algorithm later in the year.
- Unit growth is the compounder. SFM ended Q1 with 483 stores, plans 40+ openings in FY2026, and disclosed 'nearly 150 new stores approved and more than 105 executed leases' — a multi-year ~10% unit pipeline that drives mid-single-digit-plus revenue growth even at flat comps.
- Margin structure is discretionary-retail, not commodity-grocer: 39.4% gross margin and a 9.2% Q1 EBIT margin, with self-distribution of meat 'nearly complete', a new Northern California DC opening in Q2, loyalty-investment anniversarying in H2, and easing shrink comps all pointing to stabilizing-to-improving margins in the back half.
- Capital return adds a per-share tailwind: $140M repurchased in Q1 (1.9M shares), $696M remaining on the $1B authorization, and FY guidance assumes 'at least $300 million in share repurchases' — shrinking the diluted share count (95.6M in Q1 vs 99.7M a year ago) and levering EPS growth.
- PATH TO 2x: ~10% unit growth + low-to-mid-single-digit comps compounds revenue to ~$11.5B by FY2027/28; held at a ~9.5% EBIT margin and buyback-shrunk share count, EPS compounds mid-teens to ~$7.10. At a 22x end-state multiple — a premium-grocer/discretionary level the comp set (FIVE, OLLI, DLTR) supports for this growth/return profile — equity reaches ~$15B, ~2x today's $7.7B, an implied ~$156/share by mid-2028. Math and assumptions are laid out explicitly in the valuation section.
Disclaimer
This is not financial advice.
This report is for informational purposes only and is not investment advice.